---
pmid: '12808450'
title: RAGE mediates amyloid-beta peptide transport across the blood-brain barrier
  and accumulation in brain.
authors:
- Deane R
- Du Yan S
- Submamaryan RK
- LaRue B
- Jovanovic S
- Hogg E
- Welch D
- Manness L
- Lin C
- Yu J
- Zhu H
- Ghiso J
- Frangione B
- Stern A
- Schmidt AM
- Armstrong DL
- Arnold B
- Liliensiek B
- Nawroth P
- Hofman F
- Kindy M
- Stern D
- Zlokovic B
journal: Nat Med
year: '2003'
full_text_available: false
doi: 10.1038/nm890
---

# RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.
**Authors:** Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B
**Journal:** Nat Med (2003)
**DOI:** [10.1038/nm890](https://doi.org/10.1038/nm890)

## Abstract

1. Nat Med. 2003 Jul;9(7):907-13. doi: 10.1038/nm890.

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and 
accumulation in brain.

Deane R(1), Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, 
Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, 
Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, 
Zlokovic B.

Author information:
(1)Frank P. Smith Laboratories for Neurosurgery, Department of Neurosurgery and 
Division of Neurovascular Biology, Center for Aging and Developmental Biology, 
University of Rochester Medical Center, Rochester, New York 14642, USA.

Amyloid-beta peptide (Abeta) interacts with the vasculature to influence Abeta 
levels in the brain and cerebral blood flow, providing a means of amplifying the 
Abeta-induced cellular stress underlying neuronal dysfunction and dementia. 
Systemic Abeta infusion and studies in genetically manipulated mice show that 
Abeta interaction with receptor for advanced glycation end products 
(RAGE)-bearing cells in the vessel wall results in transport of Abeta across the 
blood-brain barrier (BBB) and expression of proinflammatory cytokines and 
endothelin-1 (ET-1), the latter mediating Abeta-induced vasoconstriction. 
Inhibition of RAGE-ligand interaction suppresses accumulation of Abeta in brain 
parenchyma in a mouse transgenic model. These findings suggest that vascular 
RAGE is a target for inhibiting pathogenic consequences of Abeta-vascular 
interactions, including development of cerebral amyloidosis.

DOI: 10.1038/nm890
PMID: 12808450 [Indexed for MEDLINE]
